Top Story

WHO outlines 'End TB Strategy'

March 28, 2015

In an article recently published in The Lancet, WHO researchers outlined and detailed the organization’s new strategy to achieve worldwide eradication of tuberculosis.

The “Global strategy and targets for tuberculosis prevention, care and control after 2015,” or the End TB strategy, was first approved May 19. Numerous stakeholders, including ministries of health, scientific institutions, financial partners, health activists, non-government organizations and national tuberculosis programs, supported the plan’s 2 year development, which has the final goal of worldwide TB elimination by 2035.

In the Journals

Younger children have highest mortality rate for Ebola

March 27, 2015
Children aged younger than 5 years are more likely to die from Ebola and experience faster progressing illness vs. adults, according to study findings discussed in a…

White House releases 5-year strategy to combat antibiotic resistance

March 27, 2015
The White House released a report today outlining the government’s plans to reduce the threat of antibiotic-resistant bacteria during the next 5 years. Developed…
In the Journals

Readmission rate after C. difficile discharge nearly double other discharges

March 27, 2015
The proportion of 30-day readmissions among patients discharged after Clostridium difficile infections was nearly twice that of other patients discharged, researchers…
In the Journals

Anti-HCV seropositivity not associated with metabolic syndrome

March 27, 2015
Anti-hepatitis C virus infection seropositivity was not associated with metabolic syndrome among Taiwanese adults, regardless of age, gender and fibrosis, according to…
More News Headlines »
CME
Conjuctivitis

Management of Pediatric Conjunctivitis and Otitis/Conjunctivitis Syndrome

This activity is supported by an educational grant from Alcon Research, LTD.

Acute bacterial conjunctivitis affects approximately 1 of every 8 children each year, and 5 million cases occur in the…
More »
Meeting News Coverage Video
thumbnail for video 4129869191001

Video: NIAID Ebola vaccine well tolerated, immunogenic

March 23, 2015
WILMINGTON, Del. — Julie Ledgerwood, DO, of the National Institute of Allergy and Infectious Diseases' Vaccine…
More »
CME CNE CPE Video
Advances in Pharmacokinetic Enhancers in HIV Treatment: What You Need to Know to Optimize Outcomes

Advances in Pharmacokinetic Enhancers in HIV Treatment: What You Need to Know to Optimize Outcomes

This activity is supported by an educational grant from Bristol-Myers Squibb.

Protease inhibitors (PIs) have played an instrumental role in decreasing mortality andmorbidity among HIV-infected…
More »
morganatic-roan